Esperion Therapeutics Inc (ESPR)
Long-Term Debt
$461.36M
Quarterly · Period ending: · USD
ESPR Long-Term Debt
Latest reported$461.36Mperiod ending
Latest reported$461.36Mperiod ending
ESPR Quarterly Long-Term Debt ($2.12M → $461.36M)
Quarterly long-term debt
High-resolution chart · PNG
ESPR long-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 461,362,000 | |
| 458,302,000 | |
| 448,912,000 | |
| 474,362,000 | |
| 240,292,000 | |
| 240,286,000 | |
| 266,221,000 | |
| 266,456,000 | |
| 502,846,000 | |
| 504,566,000 | |
| 263,214,000 | |
| 262,441,000 | |
| 261,098,000 | |
| 260,564,000 | |
| 259,534,000 | |
| 513,192,000 | |
| 512,386,000 | |
| 258,804,000 | |
| 507,341,000 | |
| 274,018,000 | |
| 448,817,000 | |
| 182,821,000 | |
| 164,352,000 | |
| 160,982,000 | |
| 3,719,000 | |
| 1,109,000 | |
| 820,000 | |
| 759,000 | |
| 792,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 140,000 | |
| 585,000 | |
| 1,022,000 | |
| 1,451,000 | |
| 1,871,000 | |
| 2,283,000 | |
| 2,688,000 | |
| 3,084,000 | |
| 3,473,000 | |
| 3,855,000 | |
| 4,299,000 | |
| 4,676,000 | |
| 4,922,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,528,845 | |
| 8,074,000 | |
| 7,948,000 | |
| 7,721,000 | |
| 7,731,000 | |
| 7,221,000 | |
| 7,437,000 | |
| 6,921,000 | |
| 5,482,000 | |
| 5,386,000 | |
| 5,129,000 | |
| 3,307,000 | |
| 3,027,000 | |
| 2,483,000 | |
| 1,975,000 | |
| 2,123,469 |